Robert Bash
Profile
Robert Bash served as the CEO of Nephera Ltd.
and FlowSense Medical Ltd.
He also worked as the CFO and Vice President of Business Development at Y-Med, Inc. and as the General Manager of Dorot Properties & Holdings Ltd.
Additionally, he was a Partner at Infinity Equity Capital Ltd.
Bash received his undergraduate degree from the University of Pennsylvania.
Former positions of Robert Bash
Companies | Position | End |
---|---|---|
Dorot Properties & Holdings Ltd.
Dorot Properties & Holdings Ltd. Real Estate DevelopmentFinance Dorot Properties & Holdings Ltd. engages in real estate businesses. Its real estate portfolio includes offices, shopping centers, hotels, warehouses, market places and parking facilities. It initiates and operates real estate projects. It operates in Bulgaria, Hungary, Poland, Slovakia and the United Kingdom. The company is headquartered in Ramat Gan, Israel. | Chief Executive Officer | 2010-10-26 |
Infinity Equity Capital Ltd
Infinity Equity Capital Ltd Investment ManagersFinance Infinity Equity Capital Ltd (Infinity Equity Capital) is a venture capital firm founded in 1993 by Chris Brenes. The firm is headquartered in Tel Aviv, Israel with additional office in Beijing. | Corporate Officer/Principal | - |
Nephera Ltd.
Nephera Ltd. Medical SpecialtiesHealth Technology Nephera Ltd. develops products to protect the kidneys via neuro-hormonal modulation. Its technology is based on electrical stimulation of the urinary bladder in order to improve renal function using natural mechanisms. The firm's product RenaSense, which is a medical device that improves and maintains kidney functionality in patients suffering from decompensate heart failure. The company was founded by Gill Bar-Yoseph and Yair Feld in 2008 and is headquartered in Caesarea, Israel. | Chief Executive Officer | - |
FlowSense Medical Ltd.
FlowSense Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology FlowSense Medical Ltd. develops and manufactures medical equipment, which is used in intensive care operating room. It engages in optimizing fluid management and acute renal care. Its product includes URINFO2000, which enables automated continuous monitoring of urine output for the optimization of fluid management and acute renal care. FlowSense Medical product URINFO2000 facilitates early indications of developing patient conditions and improve the effectiveness of treatment in cases such as cardio-renal syndrome, shock, pre-op/post-op complications, hypervolemia, hypovolemia, pulmonary edema and other comorbidities. The company was founded in 2009 and is headquartered in Misgav, Israel. | Chief Executive Officer | - |
Y-Med, Inc.
Y-Med, Inc. Medical SpecialtiesHealth Technology Y-Med, Inc. develops and manufactures medical devices for vascular intervention providing less invasive therapies for a broad range of circulatory diseases. The company was founded in 2004 and is headquartered in San Diego, CA. | Director of Finance/CFO | - |
Training of Robert Bash
University of Pennsylvania | Undergraduate Degree |
Experiences
Positions held
Linked companies
Private companies | 5 |
---|---|
Y-Med, Inc.
Y-Med, Inc. Medical SpecialtiesHealth Technology Y-Med, Inc. develops and manufactures medical devices for vascular intervention providing less invasive therapies for a broad range of circulatory diseases. The company was founded in 2004 and is headquartered in San Diego, CA. | Health Technology |
Dorot Properties & Holdings Ltd.
Dorot Properties & Holdings Ltd. Real Estate DevelopmentFinance Dorot Properties & Holdings Ltd. engages in real estate businesses. Its real estate portfolio includes offices, shopping centers, hotels, warehouses, market places and parking facilities. It initiates and operates real estate projects. It operates in Bulgaria, Hungary, Poland, Slovakia and the United Kingdom. The company is headquartered in Ramat Gan, Israel. | Finance |
FlowSense Medical Ltd.
FlowSense Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology FlowSense Medical Ltd. develops and manufactures medical equipment, which is used in intensive care operating room. It engages in optimizing fluid management and acute renal care. Its product includes URINFO2000, which enables automated continuous monitoring of urine output for the optimization of fluid management and acute renal care. FlowSense Medical product URINFO2000 facilitates early indications of developing patient conditions and improve the effectiveness of treatment in cases such as cardio-renal syndrome, shock, pre-op/post-op complications, hypervolemia, hypovolemia, pulmonary edema and other comorbidities. The company was founded in 2009 and is headquartered in Misgav, Israel. | Electronic Technology |
Nephera Ltd.
Nephera Ltd. Medical SpecialtiesHealth Technology Nephera Ltd. develops products to protect the kidneys via neuro-hormonal modulation. Its technology is based on electrical stimulation of the urinary bladder in order to improve renal function using natural mechanisms. The firm's product RenaSense, which is a medical device that improves and maintains kidney functionality in patients suffering from decompensate heart failure. The company was founded by Gill Bar-Yoseph and Yair Feld in 2008 and is headquartered in Caesarea, Israel. | Health Technology |
Infinity Equity Capital Ltd
Infinity Equity Capital Ltd Investment ManagersFinance Infinity Equity Capital Ltd (Infinity Equity Capital) is a venture capital firm founded in 1993 by Chris Brenes. The firm is headquartered in Tel Aviv, Israel with additional office in Beijing. | Finance |
- Stock Market
- Insiders
- Robert Bash